- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case C-261/21: Judgment of the Court (Ninth Chamber) of 7 July 2022 (request for a preliminary ruling from the Consiglio di Stato — Italy) — F. Hoffmann-La Roche Ltd, Novartis AG, Novartis Farma SpA, Roche SpA v Autorità Garante della Concorrenza e del Mercato (Reference for a preliminary ruling — Second subparagraph of Article 19(1) TEU — Obligation on Member States to provide remedies sufficient to ensure effective legal protection in the fields covered by EU law — Article 267 TFEU — Obligation on the referring court to give full effect to the interpretation of EU law provided by the Court of Justice — Charter of Fundamental Rights of the European Union — Article 47 — Access to an independent and impartial tribunal previously established by law — Judgment of a national court of last instance after a preliminary ruling by the Court — Alleged non-conformity of that judgment with the interpretation of EU law provided by the Court — National legislation preventing the bringing of an action for revision of that judgment)
ECLI:EU:UNKNOWN:62021CA0261
62021CA0261
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
Official Journal of the European Union
C 318/16
(Case C-261/21) (*)
(Reference for a preliminary ruling - Second subparagraph of Article 19(1) TEU - Obligation on Member States to provide remedies sufficient to ensure effective legal protection in the fields covered by EU law - Article 267 TFEU - Obligation on the referring court to give full effect to the interpretation of EU law provided by the Court of Justice - Charter of Fundamental Rights of the European Union - Article 47 - Access to an independent and impartial tribunal previously established by law - Judgment of a national court of last instance after a preliminary ruling by the Court - Alleged non-conformity of that judgment with the interpretation of EU law provided by the Court - National legislation preventing the bringing of an action for revision of that judgment)
(2022/C 318/21)
Language of the case: Italian
Parties to the main proceedings
Applicants: F. Hoffmann-La Roche Ltd, Novartis AG, Novartis Farma SpA, Roche SpA
Defendant: Autorità Garante della Concorrenza e del Mercato
Interveners: Società Oftalmologica Italiana (SOI) — Associazione Medici Oculisti Italiani (AMOI), Regione Emilia-Romagna, Regione Lombardia, Altroconsumo, Novartis Farma SpA, Roche SpA, Novartis AG, F. Hoffmann-La Roche Ltd, Associazione Italiana delle Unità Dedicate Autonome Private di Day Surgery e dei Centri di Chirurgia Ambulatoriale (Aiudapds), Coordinamento delle associazioni per la tutela dell’ambiente e dei diritti degli utenti e consumatori (Codacons), Ministero della Salute — Agenzia Italiana del Farmaco
Operative part of the judgment
Article 4(3) and Article 19(1) TEU, and Article 267 TFEU, read in the light of Article 47 of the Charter of Fundamental Rights of the European Union, must be interpreted as not precluding provisions of procedural law of a Member State which, while observing the principle of equivalence, have the effect that, where the supreme court of the administrative system of that Member State gives a decision settling a dispute in which it had made a request to the Court of Justice for a preliminary ruling under Article 267 TFEU, the parties to that dispute may not seek a revision of that decision of the national court based on the contention that the latter disregarded the interpretation of EU law provided by the Court of Justice in response to that request.
(*) Language of the case: Italian.